Comparative evaluation of techniques for the manufacturing of dendritic cell-based cancer vaccines

Journal of Cellular and Molecular Medicine

Volumn 13, Issue 1, 2009, Pages 125-135

  Dohnal, Alexander Michael ^a,b   Graffi, Sebastian ^a,c   Witt, Volker ^d   Eichstill, Christina ^b   Wagner, Dagmar ^b   Ul Haq, Sidrah ^a   Wimmer, Doris ^b,c   Felzmann, Thomas ^a,b,e  

^a St Anna Children's Cancer Research Institute   (Austria)

^b Trimed Biotech GmbH   (Austria)

^c Wilhelminen Krebsforschung   (Austria)

^d ST ANNA CHILDREN S HOSPITAL   (Austria)

^e CHILDREN'S CANCER RESEARCH INSTITUTE   (Austria)

Author keywords

Cancer vaccination; Dendritic cell manufacturing; Good manufacturing practice; In line monocyte enrichment; Quality control

Indexed keywords

CANCER VACCINE; GAMMA INTERFERON; INTERLEUKIN 12; LIPOPOLYSACCHARIDE;

APHERESIS; ARTICLE; CELL SEPARATION; CYTOLOGY; DENDRITIC CELL; EVALUATION; HUMAN; IMMUNOLOGY; LEUKOCYTE; METHODOLOGY; MONOCYTE; NEOPLASM;

BLOOD COMPONENT REMOVAL; CANCER VACCINES; CELL SEPARATION; DENDRITIC CELLS; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-12; LEUKOCYTES; LIPOPOLYSACCHARIDES; MONOCYTES; NEOPLASMS;

EID: 58649089564     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2008.00304.x     Document Type: Article

References (27)

1. Steinman RM, Banchereau J. Taking dendritic cells into medicine. Nature. 2007 449 : 419 26.
2. Banchereau J, Palucka AK, Dhodapkar M, Burkeholder S, Taquet N, Rolland A, Taquet S, Coquery S, Wittkowski KM, Bhardwaj N, Pineiro L, Steinman R, Fay J. Immune and clinical responses in patients with metastatic melanoma to CD34(+) progenitor-derived dendritic cell vaccine. Cancer Res. 2001 61 : 6451 8.
3. Schadendorf D, Ugurel S, Schuler-Thurner B, Nestle FO, Enk A, Brocker EB, Grabbe S, Rittgen W, Edler L, Sucker A, Zimpfer-Rechner C, Berger T, Kamarashev J, Burg G, Jonuleit H, Tuttenberg A, Becker JC, Keikavoussi P, Kampgen E, Schuler G. Dacarbazine (DTIC) versus vaccination with autologous peptide-pulsed dendritic cells (DC) in first-line treatment of patients with metastatic melanoma: a randomized phase III trial of the DC study group of the DeCOG. Ann Oncol. 2006 17 : 563 70.
4. Vakkila J, Lehtonen E, Koskimies S, Hurme M. Dendritic cells in human peripheral blood: effective enrichment from the nonadherent cells. Immunol Lett. 1987 15 : 229 36.
5. Felzmann T, Witt V, Wimmer D, Ressmann G, Wagner D, Paul P, Huttner K, Fritsch G. Monocyte enrichment from leukapharesis products for the generation of DCs by plastic adherence, or by positive or negative selection. Cytotherapy. 2003 5 : 391 8.
6. Padley DJ, Dietz AB, Gastineau DA, Vuk-Pavlovic S. Mature myeloid dendritic cells for clinical use prepared from CD14+ cells isolated by immunomagnetic adsorption. J Hematother Stem Cell Res. 2001 10 : 427 9.
7. Bender A, Sapp M, Schuler G, Steinman RM, Bhardwaj N. Improved methods for the generation of dendritic cells from non-proliferating progenitors in human blood. J Immunol Methods. 1996 196 : 121 35.
8. Suen Y, Lee SM, Aono F, Hou S, Loudovaris M, Ofstein G, Bender JG. Comparison of monocyte enrichment by immuno-magnetic depletion or adherence for the clinical-scale generation of DC. Cytotherapy. 2001 3 : 365 75.
9. Berger TG, Strasser E, Smith R, Carste C, Schuler-Thurner B, Kaempgen E, Schuler G. Efficient elutriation of monocytes within a closed system (Elutra) for clinical-scale generation of dendritic cells. J Immunol Methods. 2005 298 : 61 72.
10. Erdmann M, Dorrie J, Schaft N, Strasser E, Hendelmeier M, Kampgen E, Schuler G, Schuler-Thurner B. Effective clinical-scale production of dendritic cell vaccines by monocyte elutriation directly in medium, subsequent culture in bags and final antigen loading using peptides or RNA transfection. J Immunother. 2007 30 : 663 74.
11. Lemarie C, Sugaye R, Kaur I, Taga T, Chabannon C, Schuyler R, McMannis J. Purification of monocytes from cryopre-served mobilized apheresis products by elutriation with the Elutra device. J Immunol Methods. 2007 318 : 30 6.
12. ten Brinke A, Karsten ML, Dieker MC, Zwaginga JJ, Vrielink H, Marieke van Ham S. Generation of dendritic cells for immunotherapy is minimally impaired by granulocytes in the monocyte preparation. Immunobiology. 2006 211 : 633 40.
13. de Jong EC, Smits HH, Kapsenberg ML. Dendritic cell-mediated T cell polarization. Springer Semin Immunopathol. 2005 26 : 289 307.
14. Felzmann T, Huttner KG, Breuer SK, Wimmer D, Ressmann G, Wagner D, Paul P, Lehner M, Heitger A, Holter W. Semi-mature IL-12 secreting dendritic cells present exogenous antigen to trigger cytolytic immune responses. Cancer Immunol Immunother. 2005 54 : 769 80.
15. Hüttner KG, Breuer SK, Paul P, Majdic O, Heitger A, Felzmann T. Generation of potent anti-tumor immunity in mice by interleukin-12-secreting dendritic cells. Cancer Immunol Immunother. 2005 54 : 67 77.
16. Langenkamp A, Messi M, Lanzavecchia A, Sallusto F. Kinetics of dendritic cell activation: impact on priming of TH1, TH2 and nonpolarized T cells. Nat Immunol. 2000 1 : 3116.
17. Dohnal A, Witt V, Hugel H, Holter W, Gadner H, Felzmann T. Phase I study of tumor Ag-loaded IL-12 secreting semi-mature DC for the treatment of pediatric cancer. Cytotherapy. 2007 9 : 755 70.
18. Suffredini AF, Hochstein HD, McMahon FG. Dose-related inflammatory effects of intravenous endotoxin in humans: evaluation of a new clinical lot of Escherichia coli O: 113 endotoxin. J Infect Dis. 1999 179 : 1278 82.
19. Felzmann T, Buchberger M, Lehner M, Printz D, Kircheis R, Wagner E, Gadner H, Holter W. Functional maturation of dendritic cells by exposure to CD40L transgenic tumor cells, fibroblasts or keratinocytes. Cancer Letters. 2001 168 : 145 54.
20. Felzmann T, Gadner H, Holter W. Dendritic cells as adjuvants in antitumor immune therapy. Onkologie. 2002 25 : 456 64.
21. Crawford K, Gabuzda D, Pantazopoulos V, Xu J, Clement C, Reinherz E, Alper CA. Circulating CD2+ monocytes are dendritic cells. J Immunol. 1999 163 : 5920 8.
22. Dohnal AM, Inthal A, Felzmann T, Glatt S, Sommergruber W, Mann G, Gadner H, Panzer-Grumayer ER. Leukemia-associated antigenic isoforms induce a specific immune response in children with T-ALL. Int J Cancer. 2006 119 : 2870 7.
23. Luft T, Maraskovsky E, Schnurr M, Knebel K, Kirsch M, Gorner M, Skoda R, Ho AD, Nawroth P, Bierhaus A. Tuning the volume of the immune response: strength and persistence of stimulation determine migration and cytokine secretion of dendritic cells. Blood. 2004 104 : 1066 74.
24. Jefford M, Schnurr M, Toy T, Masterman KA, Shin A, Beecroft T, Tai TY, Shortman K, Shackleton M, Davis ID, Parente P, Luft T, Chen W, Cebon J, Maraskovsky E. Functional comparison of DCs generated in vivo with Flt3 ligand or in vitro from blood monocytes: differential regulation of function by specific classes of physiologic stimuli. Blood. 2003 102 : 1753 63.
25. Thomas R, Lipsky PE. Human peripheral blood dendritic cell subsets. Isolation and characterization of precursor and mature antigen-presenting cells. J Immunol. 1994 153 : 4016 28.
26. Timmerman JM, Czerwinski DK, Davis TA, Hsu FJ, Benike C, Hao ZM, Taidi B, Rajapaksa R, Caspar CB, Okada CY, van Beckhoven A, Liles TM, Engleman EG, Levy R. Idiotype-pulsed dendritic cell vaccination for B-cell lymphoma: clinical and immune responses in 35 patients. Blood. 2002 99 : 1517 26.
27. Davis ID, Chen Q, Morris L, Quirk J, Stanley M, Tavarnesi ML, Parente P, Cavicchiolo T, Hopkins W, Jackson H, Dimopoulos N, Tai TY, MacGregor D, Browning J, Svobodova S, Caron D, Maraskovsky E, Old LJ, Chen W, Cebon J. Blood dendritic cells generated with Flt3 lig-and and CD40 ligand prime CD8+ T cells efficiently in cancer patients. J Immunother. 2006 29 : 499 511.